Neurocrine Biosciences (NBIX) Return on Invested Capital [ROIC] (2020 - 2024)
Neurocrine Biosciences (NBIX) reported Return on Invested Capital [ROIC] of 15.09% for Q4 2024, up 6.85 percentage points from 8.25% a year earlier but down 1.29 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Return on Invested Capital [ROIC] (2020 - 2024) Analysis & Trends
For FY2024, Neurocrine Biosciences posted Return on Invested Capital [ROIC] of 16.05%, up 7.24 percentage points from FY2023.
- Return on Invested Capital [ROIC] has a four-year change of +1.04 percentage points (FY2020 to FY2024).
- By year, Return on Invested Capital [ROIC] came in at 8.82% in FY2023 (-2.25 pp), 11.06% in FY2022 (+3.82 pp), 7.25% in FY2021 (-7.76 pp) and 15.01% in FY2020.
- Five-year quarterly Return on Invested Capital [ROIC] spans a low of 5.31% in Q1 2023 and a high of 16.38% in Q3 2024.
- Year over year, Return on Invested Capital [ROIC] has now increased in each of the last four quarters, with an average year-over-year change of +6.75 percentage points over the last five quarters.
- Per Business Quant data, the three quarters before Q4 2024 came in at 16.38% (Q3 2024), 16.22% (Q2 2024) and 14.88% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 15.09% |
| Sep 30, 2024 | 16.38% |
| Jun 30, 2024 | 16.22% |
| Mar 31, 2024 | 14.88% |
| Dec 31, 2023 | 8.25% |
| Sep 30, 2023 | 7.38% |
| Jun 30, 2023 | 6.12% |
| Mar 31, 2023 | 5.31% |
| Dec 31, 2022 | 10.02% |
| Dec 31, 2020 | 13.84% |
| Sep 30, 2020 | 10.18% |
API Access
Neurocrine Biosciences Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();